BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10505584)

  • 1. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.
    Bauer M; Dopfmer S
    J Clin Psychopharmacol; 1999 Oct; 19(5):427-34. PubMed ID: 10505584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.
    Crossley NA; Bauer M
    J Clin Psychiatry; 2007 Jun; 68(6):935-40. PubMed ID: 17592920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium augmentation therapy in refractory depression-update 2002.
    Bauer M; Forsthoff A; Baethge C; Adli M; Berghöfer A; Döpfmer S; Bschor T
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium augmentation in antidepressant-resistant patients. A quantitative analysis.
    Austin MP; Souza FG; Goodwin GM
    Br J Psychiatry; 1991 Oct; 159():510-4. PubMed ID: 1836411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapies in antidepressive drug refractory depression--an overview].
    Schmauss M; Erfurth A
    Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1983 Dec; 40(12):1335-42. PubMed ID: 6418110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.
    Aronson R; Offman HJ; Joffe RT; Naylor CD
    Arch Gen Psychiatry; 1996 Sep; 53(9):842-8. PubMed ID: 8792761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
    Bauer M; Adli M; Bschor T; Pilhatsch M; Pfennig A; Sasse J; Schmid R; Lewitzka U
    Neuropsychobiology; 2010; 62(1):36-42. PubMed ID: 20453533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and mechanisms of action of lithium augmentation in refractory major depression.
    Bschor T; Bauer M
    Curr Pharm Des; 2006; 12(23):2985-92. PubMed ID: 16918427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of lithium to augment antidepressant medication.
    Rouillon F; Gorwood P
    J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.
    Nelson JC; Baumann P; Delucchi K; Joffe R; Katona C
    J Affect Disord; 2014 Oct; 168():269-75. PubMed ID: 25069082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
    Nierenberg AA; Papakostas GI; Petersen T; Montoya HD; Worthington JJ; Tedlow J; Alpert JE; Fava M
    J Clin Psychopharmacol; 2003 Feb; 23(1):92-5. PubMed ID: 12544380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lithium in the treatment of acute depression].
    Adli M; Bschor T; Canata B; Döpfmer S; Bauer M
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10):435-41. PubMed ID: 9825248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of treatments for refractory depression in older people.
    Cooper C; Katona C; Lyketsos K; Blazer D; Brodaty H; Rabins P; de Mendonça Lima CA; Livingston G
    Am J Psychiatry; 2011 Jul; 168(7):681-8. PubMed ID: 21454919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lithium augmentation in the management of major depressive disorder.
    Bauer M; Adli M; Ricken R; Severus E; Pilhatsch M
    CNS Drugs; 2014 Apr; 28(4):331-42. PubMed ID: 24590663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.